{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Use of Bruton tyrosine kinase inhibitors (BTKI) in patients with Waldenstrom macroglobulinemia (WM) with neuropathy and Bing-Neel syndrome, and non-IgM lymphoplasmacytic lymphoma","item":"https:\/\/www.regionalcancercare.org\/trials\/use-of-bruton-tyrosine-kinase-inhibitors-btki-in-patients-with-waldenstrom-macroglobulinemia-wm-with-neuropathy-and-bing-neel-syndrome-and-non-igm-lymphoplasmacytic-lymphoma\/#breadcrumbitem"}]}